Skip to main content
TipRanks
Go Ultimate75% OFF

Top Glove Bhd (TGLVY) AI Stock Analysis

57 Followers
TGLVY

Top Glove Bhd

(Other OTC:TGLVY)

Select Model
Rating:69Neutral
Price Target:$1.00â–²(22.25% Upside)
Action:reiterated
Date:10/08/26

Strong financial performance from post-pandemic recovery and positive technical indicators are the main drivers, with valuation providing a neutral contribution.

Positive Factors
Profitability RecoveryThe return to solid profitability alongside higher TTM revenue indicates that the business has recovered from its recent downturn. Sustained positive margins would improve internal funding capacity, support reinvestment, and provide a stronger base for earnings over the next several quarters.
Negative Factors
High Earnings CyclicalityThe sharp movement from exceptional pandemic profits to later losses demonstrates substantial earnings sensitivity to industry conditions. This cyclicality makes the current recovery less predictable, complicates long-term planning, and increases the risk that future profitability will fluctuate materially rather than compound steadily.

Top Glove Bhd (TGLVY) vs. SPDR S&P 500 ETF (SPY)

-20%0%20%40%60%80%TGLVY+47.12%SPY+13.31%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$1.64B
Dividend Yield
0.57%
Average Volume (3M)
1,724
Price to Earnings (P/E)
24.5
Beta (1Y)
-0.24
Revenue Growth
30.02%
EPS Growth
203.20%
Country
US
Employees
10,600
Sector
Healthcare
Sector Strength
51
Industry
Medical - Instruments & Supplies

Top Glove Bhd Business Overview & Revenue Model

Company Description

Top Glove Corporation Bhd., established in 1991 and based in Shah Alam, Malaysia, functions primarily as an investment holding entity while also furnishing a range of management services. Its extensive manufacturing operations yield a broad spectrum...

How the Company Makes Money

Top Glove primarily makes money by manufacturing disposable gloves and selling them to customers in domestic and international markets. Revenue is generated from (1) sales of glove products across different material types (e.g., natural rubber latex...

Top Glove Bhd Financial Statement Overview

Summary

Recovery shown in 9.4% revenue growth and 7.3% net margins, supported by low debt-to-equity of 0.17 and positive free cash flow of 325 million.

Income Statement

65Positive

Balance Sheet

82Very Positive

Cash Flow

70Positive
Financial statement breakdown
BreakdownTTMAug 2026Aug 2025Aug 2024Aug 2023Aug 2022
Income Statement
Total Revenue4.24B4.05B3.49B2.51B2.26B5.57B
Gross Profit2.22B389.07M89.01M265.32M64.32M953.38M
EBITDA715.55M696.52M455.66M266.09M-544.66M711.00M
Net Income307.50M294.90M132.18M-18.27M-878.61M275.73M
Balance Sheet
Total Assets6.69B6.69B6.27B6.96B7.06B8.12B
Cash, Cash Equivalents and Short-Term Investments978.20M978.20M560.67M933.23M942.82M946.75M
Total Debt852.95M852.95M849.86M422.09M581.85M417.07M
Total Liabilities1.69B1.69B1.49B1.12B1.14B1.32B
Stockholders Equity4.97B4.97B4.76B5.81B5.89B6.75B
Cash Flow
Free Cash Flow324.53M415.97M156.31M-122.54M-244.10M-774.72M
Operating Cash Flow423.76M529.12M300.16M20.70M121.04M178.81M
Investing Cash Flow-324.78M-413.57M450.90M247.46M-383.26M132.42M
Financing Cash Flow-26.20M-30.38M-803.47M-181.66M94.75M-740.35M

Top Glove Bhd Technical Analysis

Technical Analysis SentimentNeutral
Last Price0.82

Price Trends

50DMA0.78Positive
100DMA0.69Positive
200DMA0.68Positive

Market Momentum

MACD0.03Positive
RSI46.40Neutral
STOCH38.92Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TGLVY, the sentiment is Neutral. The current price of 0.82 is below the 20-day moving average (MA) of 0.88, above the 50-day MA of 0.78, and above the 200-day MA of 0.68, indicating a neutral trend. The MACD of 0.03 indicates Positive momentum. The RSI at 46.40 is Neutral, neither overbought nor oversold. The STOCH value of 38.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TGLVY.

Top Glove Bhd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

TGLVY against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TGLVYTGLVY69Neutral$1.84B24.486.39%0.57%30.02%203.20%
MDLNMDLN65Neutral$51.53B58.554.97%―11.85%-57.19%
ICUIICUI64Neutral$4.55B75.922.81%―-5.82%―
BDXBDX63Neutral$58.96B52.244.64%1.84%-7.40%-28.89%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
SOLVSOLV50Neutral$15.05B99.833.18%―-3.09%-89.72%
BAXBAX46Neutral$13.21B-18.62-11.62%0.16%5.33%-164.67%

* Healthcare Sector Average

Performance Comparison

0%25%50%75%TGLVYBAXBDXICUISOLVMDLNDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TGLVY and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TGLVYTop Glove Corporation0.820.3263.93%
BAXBaxter International Inc25.547.4340.99%
BDXBecton, Dickinson and Co216.4769.0146.80%
ICUIICU Medical181.8747.8435.69%
SOLVSolventum Corporation88.6511.7615.29%
MDLNMedline, Inc. Class A39.17-1.83-4.46%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 08, 2026